Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients

By afschroeder • July 21, 2026

Bishop CW, Ashfaq A, Strugnell SA, Choe J, Patel N, Norris KC, Sprague SM. Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients. Am J Nephrol. 2026;57(4):504-513. doi: 10.1159/000541138. Epub 2024 Aug 27. PMID: 39191216; PMCID: PMC13384448.

Tags: Chronic kidney disease, Extended-release calcifediol, General Internal Medicine, Parathyroid hormone, Progression, Publications, secondary hyperparathyroidism

Could School Function Be an Adolescent Health Vital Sign? Associations Between Gradebook Data and Substance Use Among Middle School Students

DiPentino R, Meza BPL, Jackson N, Dosanjh KK, Dudovitz RN, Wong MD. Could School Function Be an Adolescent Health Vital Sign? Associations Between Gradebook Data[...]

Safety and Efficacy of the Ahmed ClearPath versus Ahmed ClearPath Small Tube at Six Months: A Retrospective Comparative Cohort Study

Shi KSY, Dorairaj EA, Bhartiya S, Oyama K, Wang W, Thé RY, Moreno KB, Wang M, Towne C, Qozat IM, Banoub RG, Dorairaj SK. Safety[...]

“Interstitial lung disease with associated severe pulmonary hypertension is rarely idiopathic by clinical or pathologic measures”

Brownstein AJ, Shaikh F, Xiao GQ, Wilhalme H, Abtin F, Stefanko DP, Liang LL, Hong J, Rahaghi F, Shino M, Samuel Weigt S, Sayah D,[...]